PREMEX S.A. – Trademark Portfolio
Entity Type: 03
PREMEX S.A. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INTERNET OF ANIMALS. The owner is based in Medellín, Antioquia.
CR 50 2 SUR 251
Medellín, Antioquia , CO
Showing of trademarks Trademarks
Trademark Classifications
PREMEX S.A.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does PREMEX S.A. have?
PREMEX S.A. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 3 cancelled.
What trademark classes does PREMEX S.A. file in?
PREMEX S.A. files trademarks across 4 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are PREMEX S.A.'s most well-known trademarks?
PREMEX S.A.'s registered trademark portfolio includes well-known marks such as INTERNET OF ANIMALS. These are among 1 currently registered trademark in the portfolio.
What is PREMEX S.A.'s trademark registration success rate?
PREMEX S.A. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.